Delivery Order SPE2DB20D2104-SPE2DB25FMVZC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,102.40 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packaging) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,047.25 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. The award, issued on July 25, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This non-competitive delivery order draws from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- This is a $6,036.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medication Lo Loestrin Fe 1-10 Tablet 28s. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $900 against the Defense Logistics Agency's prime vendor contract to provide the Defense Department with 28-count packages of Lo Loestrin FE 1-10mg tablets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in July 2023. Pricing is firm fixed. No subcontractors or set-aside designations were identified....
- This is a $1,857.36 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The order is for the drug Lo Loestrin Fe 1-10 Tablet 28s and has a completion date of June 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,559.94 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 1,056 units of Lo Loestrin FE 1-10 tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies to be delivered by October 30, 2023. No set-aside designation was applied to this order, which was awarded under the full and open market procedures...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, to provide Lo Loestrin Fe 1-10 tablet 28s. The order has a ceiling value of $39,912.13 and an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This delivery order is one of many that...
- This federal contract award is a $5,149.80 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
- The Defense Logistics Agency Troop Support Medical awarded a $22,345 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Specifically, the order is for 4561401363 units of Lo Loestrin FE 1-10 tablet 28s to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance spans from July 3, 2023 to July 5, 2023. As the Defense Logistics Agency manages the global supply chain for the U.S. military's...
- The Defense Logistics Agency Troop Support Medical awarded a $5,401.85 delivery order to Amerisourcebergen Drug Corp for the provision of 4561896163 LO LOESTRIN FE 1-10 TABLET 28S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The firm fixed price order has a period of performance from August 22, 2023 through August 23, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Corporation will fulfill this order...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVZCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 billion through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The delivery order demonstrates the company's ongoing role in fulfilling Defense Health Agency pharmaceutical requirements through the DLA's supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/21/25 |